Their research highlighted that PD-L1 expression was present in 10.4% of large-cell neuroendocrine carcinoma (LCNEC) cases and 5.8% of small-cell lung cancer (SCLC) cases, whereas it was absent in typical and atypical carcinoid tumors [38]. Here, CD274 is linked to small cell lung carcinoma.